Unosource Pharma Limited - pharma in Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U24233DL2013PLC262364 Incorporated 18 December 2013 ROC Delhi HQ Delhi, Delhi, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹147.51 Cr
▲ 14.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹18.02 Cr
Issued & subscribed
Open charges
₹20 Cr
Satisfied ₹7 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
41
Latest available

About Unosource Pharma Limited

Data last updated: 05 January 2026

Unosource Pharma Limited is a public limited company based in Delhi, Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 18 December 2013, the company has been in operation for over 13 years.

Registered with ROC Delhi under CIN U24233DL2013PLC262364.

Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹18.02 Cr. It is led by directors including Sanjay Chandrakant Chalke and Manju Bist.

Last AGM: 15 June 2025. Financial statements filed for year ended 31 March 2025. Office: 305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, Delhi, India – 110034.

As per the financials filed for FY 2025, the company reported a revenue of ₹147.51 Cr, a growth of 14% compared to the previous year.

The company has a workforce of approximately 41 employees as per the latest available data. It operates as a subsidiary of Akums Drugs And Pharmaceuticals Limited.

The company is associated with 2 brands - Akums, Unosource Pharma. As per MCA filings, the company has open charges of ₹20 Cr and satisfied charges of ₹7 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unosourcepharma.com.

Company Details of Unosource Pharma Limited
CIN U24233DL2013PLC262364
Registration Number 262364
Incorporation Date 18 December 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Akums Drugs And Pharmaceuticals Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, Delhi, India – 110034
  • Industry
    Pharma, Drug Formulation & Development
Company report
Unosource Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Unosource Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Unosource Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Unosource Pharma Limited

Unosource Pharma Limited operates two associated brands: Akums and Unosource Pharma. These brands represent Unosource Pharma Limited's diversified market presence and brand portfolio.

Brand Description Website
CDMO focusing on spectrum of dosage forms and therapeutic segments akums.in
Pharmaceutical manufacturing, exporting, and CDMO services. unosourcepharma.com

Competitors & Alternatives of Unosource Pharma Limited

Brands and companies operating in the same space as Unosource Pharma Limited include Jubilant Life Sciences, Nectar Lifesciences, Windlas and 6 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
Aenova Group Aenova Group CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. Starnberg, Germany, Germany 2008
Zambon Pharma Zambon Pharma APIs and finished drugs are developed and manufactured in pharmaceuticals. Bresso, Italy, Italy 1906
Leukocare Leukocare Proprietary stabilizing solutions for biologics formulations are developed. Munich, Germany, Germany 2003

Business Activity of Unosource Pharma Limited

Unosource Pharma Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q6 Other Hospital and Medical Care Activities Locked
Premium access

Business activity turnover details for Unosource Pharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Unosource Pharma Limited

Unosource Pharma Limited is audited by Walker Chandiok & Co. LLP for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Walker Chandiok & Co. LLP Locked Locked Locked
Premium access

Complete auditor history for Unosource Pharma Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Unosource Pharma Limited

Unosource Pharma Limited currently reports 3 directors and 1 key managerial person. 16 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Sanjay Chandrakant Chalke Director 13 Jan 2017 9 Years 7 Months Current
Manju Bist Director 20 Aug 2024 1 Years 11 Months Current
Sumeet Sood Cfo 10 Jun 2022 4 Years 2 Months Current
Manmohan Singh Director 15 Jun 2015 11 Years 1 Months Current

Financials of Unosource Pharma Limited FY 2025 filings available

Unosource Pharma Limited reported revenue of ₹147.51 Cr (up 14.00% YoY) for FY 2025.

Revenue · FY 2025
₹147.51 Cr ▲ 14.00%
Premium access

Ten-year financial statements for Unosource Pharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Unosource Pharma Limited

Premium access

Shareholding and ownership data for Unosource Pharma Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Unosource Pharma Limited

Open charges
₹20 Cr
Satisfied charges
₹7 Cr
Breakdown by lending institutions
Citi Bank N.A.₹5.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹5.00 Cr
Others₹5.00 Cr
Hdfc Bank Limited₹5.00 Cr
Latest charge details
DateLenderAmountStatus
17 Sep 2025 Hdfc Bank Limited ₹5 Cr Open
11 Sep 2023 Others ₹5 Cr Open
14 Jul 2023 The Hongkong and Shanghai Banking Corporation Limited ₹5 Cr Open
16 Dec 2022 Citi Bank N.A. ₹5 Cr Open
02 Apr 2018 Yes Bank Limited ₹5 Cr Satisfied

Total charge records: 6 View all charges

Employees and EPFO Compliance at Unosource Pharma Limited

Unosource Pharma Limited has a workforce of 41 employees as of Apr 09, 2024.

Employee count
41
Active EPFO establishments
1
Employee growth
5.13%
Premium access

Employee and EPFO history for Unosource Pharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Unosource Pharma Limited

Premium access

GST registrations and filing compliance for Unosource Pharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Unosource Pharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Unosource Pharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Unosource Pharma Limited

Premium access

MSME payment history for Unosource Pharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Unosource Pharma Limited

Premium access

Corporate group structure for Unosource Pharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Unosource Pharma Limited

Premium access

MCA filings and documents for Unosource Pharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Unosource Pharma Limited

Charges
17 Sep 2025
A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101162760 was registered on 17 Sep 2025.
Charges
28 Jul 2025
A charge with Citi Bank N.A. of Rs. 5.00 Cr registered on 16 Dec 2022 with Charge ID 100663687 was modified on 28 Jul 2025.
Activity
15 Jun 2025
Unosource Pharma Limited last Annual general meeting of members was held on 15 Jun 2025 as per latest MCA records.
Charges
22 May 2025
A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 5.00 Cr registered on 14 Jul 2023 with Charge ID 100749854 was modified on 22 May 2025.
Activity
31 Mar 2025
Unosource Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Directors
20 Aug 2024
Manju Bist was appointed as a Director on 20 Aug 2024 & has been associated with this company since 1 year 11 months.

Frequently Asked Questions about Unosource Pharma Limited

Unosource Pharma Limited is an active public limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 18 December 2013 (13+ years old) and is registered under CIN U24233DL2013PLC262364. The company has 41 employees.

Unosource Pharma Limited reported revenue of ₹147.51 Cr for FY 2025 (up 14.00% YoY).

The current directors and KMP of Unosource Pharma Limited are:

The primary industry of Unosource Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Unosource Pharma Limited can be reached at the registered office: 305 Third Floor C – Block Plot No. 5 Mohan Place Saraswati Vihar, Delhi, Delhi, India – 110034, or through the website unosourcepharma.com.

The authorised capital is ₹20 Cr, and the paid-up capital is ₹18.02 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available